Novel insights into circular RNAs in clinical application of carcinomas
- PMID: 28458561
- PMCID: PMC5403007
- DOI: 10.2147/OTT.S134403
Novel insights into circular RNAs in clinical application of carcinomas
Abstract
Circular RNAs (circRNAs), formed by nonsequential back-splicing of pre-messenger RNA (pre-mRNA) transcripts, have been widely concerned in recent years. With advances in high-throughput RNA sequencing (RNA-seq) technology, previous work has revealed that a large number of circRNAs, which are endogenous, abundant and stable in mammalian cells, may be involved in atherosclerotic vascular disease risk, neurological disorders, prion diseases and carcinomas. Remarkably, interaction between circRNAs and microRNA has already been observed to perform a significant role in a variety of cancers, including gastric cancer and colorectal cancer. Recent work has suggested that circRNAs may play critical roles in the initiation and development of cancers and could become potential new biomarkers for cancers. Herein, we review the current understanding of the roles of circRNAs in cancers and the potential implications of circRNAs in cancer-targeted therapy.
Keywords: circular; diagnosis; microRNA; noncoding RNA; targeted therapy.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
-
- Capel B, Swain A, Nicolis S, et al. Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell. 1993;73(5):1019–1030. - PubMed
-
- Nigro JM, Cho KR, Fearon ER, et al. Scrambled exons. Cell. 1991;64:607–613. - PubMed
-
- Wang H, Yang J, Yang J, et al. Circular RNAs: novel rising stars in cardiovascular disease research. Int J Cardiol. 2016;202:726–727. - PubMed
-
- Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
